Cancer Immunology, Immunotherapy

, Volume 31, Issue 4, pp 250–254 | Cite as

Common variable immunodeficiency and malignancy: a report of two cases and possible explanation for the association

  • Igor Vorechovsky
  • Jiri Litzman
  • Jindrich Lokaj
  • Petr Hausner
  • Tomas Poch
Original articles


Two patients with common variable immunodeficiency (CVID) and malignant tumours are reported. The first patient developed myelogenous leukaemia soon after the myelodysplastic syndrome has been diagnosed. The undifferentiated gastric lymphoma found in the second patient suggests that an increased risk of gastrointestinal malignancies in CVID could partly be due to lymphomas. We hypothesize that the tissue- or site-specific risk of lymphomas and gastrointestinal cancer can be explained by an increased chromosomal or genomic instability with a higher mutation rate and genomic disorganization, and that this instability could be related to viral carcinogenesis. The primary immunodeficiency per se may not be responsible for the cancer susceptibility in CVID patients.


Lymphoma Cancer Research Malignant Tumour Mutation Rate Myelodysplastic Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aiuti F, Paganelli R, Palmisano L (1983) Complications in primary immunodeficiencies. In: Chandra RK (ed) Primary and secondary immunodeficiency disorders. Churchill Livingstone, Edinburgh, pp 149–153Google Scholar
  2. 2.
    Bennett JM, Catowsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199PubMedGoogle Scholar
  3. 3.
    Burnett FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13: 1–27PubMedGoogle Scholar
  4. 4.
    Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9: 22–33PubMedGoogle Scholar
  5. 5.
    Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P (1987) Incidence of cancer in 98 patients with common variable immunodeficiency. J Clin Immunol 7: 294–299PubMedGoogle Scholar
  6. 6.
    Den Hartog G, Van Der Meer JWM, Jansen JBMJ, Van Furth R, Lamers CBHW (1988) Decreased gastrin secretion in patients with late-onset hypogammaglobulinemia. N Engl J Med 318: 1563–1567PubMedGoogle Scholar
  7. 7.
    Den Otter W (1985) Tumor cells do not arise frequently. Cancer Immunol Immunother 19: 159–162PubMedGoogle Scholar
  8. 8.
    Den Otter W (1986) Immune surveillance and natural resistance: an evaluation. Cancer Immunol Immunother 21: 85–92PubMedGoogle Scholar
  9. 9.
    Durham JC, Stephens DS, Rimland D, Nassar VH, Spira TJ (1987) Common variable hypogammaglobulinemia complicated by an unusual T-suppressor/cytotoxic cell lymphoma. Cancer 59: 271–276PubMedGoogle Scholar
  10. 10.
    Fraumeni JF Jr, Hoover R (1977) Immunosurveillance and cancer: epidemiologic observations. Natl Cancer Inst Mongr 47: 121–126Google Scholar
  11. 11.
    Gallo RC, Wong-Staal F (1982) Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood 60: 545–557PubMedGoogle Scholar
  12. 12.
    Gatti RA, Good RA (1971) Occurrence of malignancy in immunodeficiency diseases. Cancer 28: 89–98PubMedGoogle Scholar
  13. 13.
    German J (1983) Chromosome mutation and neoplasia. Liss, New York, p 452Google Scholar
  14. 14.
    Gleichmann E, Gleichmann H, Schwartz RS, Weinblatt A, Armstrong MYK (1975) Immunological induction of malignant lymphoma: identification of donor and host tumors in the graft-versushost model. J Natl Cancer Inst 54: 107–116PubMedGoogle Scholar
  15. 15.
    Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS (1981) Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res 41: 4253–4261PubMedGoogle Scholar
  16. 16.
    Hermans PE, Diax-Buxo JA, Stobo JD (1976) Idiopathic late onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 61: 221–237PubMedGoogle Scholar
  17. 17.
    Hewitt HB, Blake ER, Walder AS (1976) A critique of the evidence for host defense against cancer based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer 33: 241–259PubMedGoogle Scholar
  18. 18.
    Hoffschir F, Ricoul M, Dutrillaux B (1988) SV-40-transformed human fibroblasts exhibit a characteristic chromosomal pattern. Cytogenet Cell Genet 49: 264–268PubMedGoogle Scholar
  19. 19.
    Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43: 403–409PubMedGoogle Scholar
  20. 20.
    Jacobson S, Biddison WE (1984) Major histocompatibility complex molecules as virus receptors. Immunol Today 5: 262Google Scholar
  21. 21.
    Jones JF, Shurim S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N Engl J Med 318: 733–741PubMedGoogle Scholar
  22. 22.
    Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, Koizumi S, Osato T, Kobayashi I, Hamada I, Hirai K (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333: 455–457PubMedGoogle Scholar
  23. 23.
    Kinlen LJ, Webster ADB, Bird AG, Haile R, Peto J, Soothill JF, Thompson RA (1985) Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet 1: 263–266PubMedGoogle Scholar
  24. 24.
    Klein G (1983) Specific chromosomal translocation and the genesis of B-cell derived tumors in mice and men. Cell 32: 311–315PubMedGoogle Scholar
  25. 25.
    Kripke ML (1988) Immunoregulation of carcinogenesis: past, present, and future. J Natl Cancer Inst 80: 722–727PubMedGoogle Scholar
  26. 26.
    Matas AJ, Simmons RL, Najarian JS (1975) Chronic antigenic stimulation, herpes virus infection, and cancer in transplant recipients. Lancet 1: 1277–1279PubMedGoogle Scholar
  27. 27.
    Nussenzweig MC, Schmidt EV, Shaw AC, Sinn E, Campos-Torres J, Mathey-Prevot B, Pattengale PK, Leder P (1988) A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nature 336: 446–450PubMedGoogle Scholar
  28. 28.
    Pienta KJ, Partin AW, Coffey DS (1989) Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49: 2525–2532PubMedGoogle Scholar
  29. 29.
    Purtilo DT (1980) Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals. Lancet 1: 300–303PubMedGoogle Scholar
  30. 30.
    Rygaard J, Povlsen CO (1974) Is immunological surveillance not a cell-mediated immune function? Transplantation 17: 135–136PubMedGoogle Scholar
  31. 31.
    Shearer WT, Ritz J, Finegold MJ (1985) Epstein-Barr virus associated with B cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. N Engl J Med 312: 1151–1159PubMedGoogle Scholar
  32. 32.
    Spector BD, Perry GS, Kersey JH (1978) Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency-cancer registry. Clin Immunol Immunopathol 11: 12–29PubMedGoogle Scholar
  33. 33.
    Spector BD, Filipovich AD, Perry GS III, Kersey JH (1982) Epidemiology of cancer in ataxia-telangiectasia. In: Bridges DA, Harnden DG (eds) Ataxia-telangiectasia — a cellular and molecular link between cancer, neuropathology, and immune deficiency. Wiley, Chichester, p 103–138.Google Scholar
  34. 34.
    Stevenson M, Volsky B, Hedenskog M, Volsky DJ (1987)) Immortalisation of human T lymphocytes after transfection of Epstein-Barr virus DNA. Science 233: 980–984Google Scholar
  35. 35.
    Stutman O (1978) Spontaneous, viral, and chemically induced tumors in the nude mouse. In: Fogh J, Giovanella B (eds) The nude mouse in experimental and clinical research. Academic Press, New York, p 411Google Scholar
  36. 36.
    Van den Brande P, Geboes K, Vantrappen G, Van den Eckhout A, Vertessen S, Stevens EAM, Ceuppens JL (1988) Intestinal nodular lymphoid hyperplasia in patients with common variable immunodeficiency: local accumulation of B and CD8+ lymphocytes. J Clin Immunol 8: 296–306PubMedGoogle Scholar
  37. 37.
    Vorechovsky I, Munzarova M, Lokaj J (1989) Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer predisposition. Cancer Immunol Immunother 29: 303–306PubMedGoogle Scholar
  38. 38.
    Vorechovsky I, Litzman J, Lokaj J, Sobotkova R (1990) Family studies in common variable immunodeficiency. J Hyg Epidemiol Microbiol Immunol (in press)Google Scholar
  39. 39.
    Waldman TA (1982) Immunological abnormalities in ataxia telangiectasia. In: Bridges DA, Harnden DG (eds) Ataxia-telangiectasia — a cellular and molecular link between cancer neuropathology, and immune deficiency. Wiley, Chichester, pp 37–51Google Scholar
  40. 40.
    Webster ADB (1976) The gut and immunodeficiency disorders. Clin Gastroenterol 5: 325–327Google Scholar
  41. 41.
    WHO (1978) Immunodeficiency. Report of a WHO Scientific Group Technical Report Series 630, GenevaGoogle Scholar

Copyright information

© Springer-Verlag 1990

Authors and Affiliations

  • Igor Vorechovsky
    • 1
  • Jiri Litzman
    • 2
  • Jindrich Lokaj
    • 2
  • Petr Hausner
    • 3
  • Tomas Poch
    • 4
  1. 1.Paediatric Research InstituteBrnoCzechoslovakia
  2. 2.Department of Clinical ImmunologyFaculty HospitalBrnoCzechoslovakia
  3. 3.Oncological Research LaboratoryFaculty of General MedicinePraha 2Czechoslovakia
  4. 4.1st. Medical ClinicFaculty of General MedicinePraha 2Czechoslovakia

Personalised recommendations